APA (7th ed.) Citation

Leclercq, M., Sève, P., Biard, L., Vautier, M., Maalouf, G., Leroux, G., . . . Desbois, A. (2025). Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. British journal of ophthalmology, 109(1), 34-40. https://doi.org/10.1136/bjo-2024-325163

Chicago Style (17th ed.) Citation

Leclercq, Mathilde, et al. "Methotrexate Versus Conventional Disease-modifying Antirheumatic Drugs in the Treatment of Non-anterior Sarcoidosis-associated Uveitis." British Journal of Ophthalmology 109, no. 1 (2025): 34-40. https://doi.org/10.1136/bjo-2024-325163.

MLA (9th ed.) Citation

Leclercq, Mathilde, et al. "Methotrexate Versus Conventional Disease-modifying Antirheumatic Drugs in the Treatment of Non-anterior Sarcoidosis-associated Uveitis." British Journal of Ophthalmology, vol. 109, no. 1, 2025, pp. 34-40, https://doi.org/10.1136/bjo-2024-325163.